These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10583429)

  • 1. Comparative inhibitory potential of differently modified antisense oligodeoxynucleotides on hepatitis C virus translation.
    Alt M; Eisenhardt S; Serwe M; Renz R; Engels JW; Caselmann WH
    Eur J Clin Invest; 1999 Oct; 29(10):868-76. PubMed ID: 10583429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core specific antisense phosphorothioate oligodeoxynucleotides as potent and specific inhibitors of hepatitis C viral translation.
    Alt M; Renz R; Hofschneider PH; Caselmann WH
    Arch Virol; 1997; 142(3):589-99. PubMed ID: 9349305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides.
    Alt M; Renz R; Hofschneider PH; Paumgartner G; Caselmann WH
    Hepatology; 1995 Sep; 22(3):707-17. PubMed ID: 7657273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro inhibition of hepatitis C virus gene expression by chemically modified antisense oligodeoxynucleotides.
    Vidalin O; Major ME; Rayner B; Imbach JL; Trépo C; Inchauspé G
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2337-44. PubMed ID: 8891141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of hepatitis C virus RNA translation by antisense bile acid conjugated phosphorothioate modified oligodeoxynucleotides (ODN).
    González-Carmona MA; Quasdorff M; Vogt A; Tamke A; Yildiz Y; Hoffmann P; Lehmann T; Bartenschlager R; Engels JW; Kullak-Ublick GA; Sauerbruch T; Caselmann WH
    Antiviral Res; 2013 Jan; 97(1):49-59. PubMed ID: 23142319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugation of an antisense oligodeoxynucleotide to ribonuclease h results in sequence-specific cleavage and intracellular inhibition of HCV gene expression.
    Fukuma T; Walton CM; Wu CH; Wu GY
    Bioconjug Chem; 2003; 14(2):295-301. PubMed ID: 12643739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the inhibitory effect of antisense oligodeoxynucleotides on the growth of hepatitis C-associated hepatocellular carcinoma cells in vitro.
    Amin MA; Awadein MR; Gabr H
    Chin J Dig Dis; 2005; 6(3):142-8. PubMed ID: 16045605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of translation of hepatitis C virus RNA by 2-modified antisense oligonucleotides.
    Brown-Driver V; Eto T; Lesnik E; Anderson KP; Hanecak RC
    Antisense Nucleic Acid Drug Dev; 1999 Apr; 9(2):145-54. PubMed ID: 10355821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorothioate antisense oligodeoxynucleotides capable of inhibiting hepatitis C virus gene expression: in vitro translation assay.
    Seki M; Honda Y
    J Biochem; 1995 Dec; 118(6):1199-204. PubMed ID: 8720135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific inhibition of hepatitis C viral gene expression by non-polar (phenylalkyl)phosphonates.
    Amberg S; Tamke A; Caselmann WH; Engels JW
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1631-4. PubMed ID: 14565483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral effects of antisense RNA on hepatitis C virus RNA translation and expression.
    Wakita T; Moradpour D; Tokushihge K; Wands JR
    J Med Virol; 1999 Mar; 57(3):217-22. PubMed ID: 10022790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of hepatitis C virus NS3 function by antisense oligodeoxynucleotides and protease inhibitor.
    Heintges T; Encke J; zu Putlitz J; Wands JR
    J Med Virol; 2001 Dec; 65(4):671-80. PubMed ID: 11745930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibition of hepatitis C virus by antisense oligodeoxynucleotide in vitro].
    Liu Y; Chen Z; He N
    Zhonghua Yi Xue Za Zhi; 1997 Aug; 77(8):567-70. PubMed ID: 9772458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes.
    Hanecak R; Brown-Driver V; Fox MC; Azad RF; Furusako S; Nozaki C; Ford C; Sasmor H; Anderson KP
    J Virol; 1996 Aug; 70(8):5203-12. PubMed ID: 8764029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific inhibition of hepatitis C virus expression by antisense oligodeoxynucleotides. In vitro model for selection of target sequence.
    Wakita T; Wands JR
    J Biol Chem; 1994 May; 269(19):14205-10. PubMed ID: 8188703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translation of stable hepadnaviral mRNA cleavage fragments induced by the action of phosphorothioate-modified antisense oligodeoxynucleotides.
    Hasselblatt P; Hockenjos B; Thoma C; Blum HE; Offensperger WB
    Nucleic Acids Res; 2005; 33(1):114-25. PubMed ID: 15640448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro.
    Yoo BH; Bochkareva E; Bochkarev A; Mou TC; Gray DM
    Nucleic Acids Res; 2004; 32(6):2008-16. PubMed ID: 15064360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
    Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
    J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The inhibitory effects of hepatocyte targeting pH-sensitive liposome mediated phosphorothioate antisense oligonucleotide on gene expression controlled by HCV 5'NCR].
    Wang XH; Wang SQ; Wen SY; Guan W; Mao BZ
    Sheng Wu Gong Cheng Xue Bao; 2001 Nov; 17(6):626-30. PubMed ID: 11910753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in mice.
    Uchida T; Gao JP; Wang C; Satoh T; Itoh I; Muramoto M; Hyodo T; Irie A; Akahoshi T; Jiang SX; Kameya T; Baba S
    Mol Urol; 2001; 5(2):71-8. PubMed ID: 11690551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.